Guardant Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Guardant Health, Inc. filed this Current Report on Form 8-K on May 6, 2021, to announce financial results for the fiscal quarter ended March 31, 2021. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Select Market under the symbol "GH."
Key Financial Metrics
This filing serves as a notification of the release of financial results and incorporates the full press release as Exhibit 99.1. The text of this Form 8-K does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached press release (Exhibit 99.1) for detailed financial data.
Material Changes
The filing does not contain specific comparative data or details regarding material changes versus the prior comparable period within the body of the report. Such information is contained in the referenced press release.
Guidance, Outlook, and Risks
The filing does not include specific guidance, outlook, management commentary, or risk factors in its text. It explicitly states that the information furnished, including the press release, is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference into other filings except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 6, 2021) for specific Q1 2021 revenue, net loss, and cash position figures.
- Verify year-over-year growth rates and margin trends in the attached press release.
- Confirm any updated full-year 2021 guidance provided in the press release.
- Check for any new material risks or contingencies disclosed in the press release text.